Valuation: Coloplast

Market Cap 92.72B 14.16B 12.4B 11.52B 10.58B 19.94B 1,366B 20.23B 137B 53.69B 668B 53.14B 52B 2,309B P/E 2026 *
29.8x
P/E 2027 * 15.5x
Enterprise Value 114B 17.34B 15.2B 14.11B 12.96B 24.43B 1,674B 24.79B 168B 65.78B 819B 65.11B 63.7B 2,829B EV / Sales 2026 *
3.95x
EV / Sales 2027 * 3.66x
Free-Float
63.42%
Yield 2026 *
4.95%
Yield 2027 * 5.33%
Manager TitleAgeSince
Chief Executive Officer 55 01/05/2026
Director of Finance/CFO 54 01/01/2006
Chief Operating Officer 59 05/09/2008
Director TitleAgeSince
Director/Board Member 78 13/12/2006
Director/Board Member 55 18/09/2009
Chairman 57 05/05/2025
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 14.23B
-1.16%+1.10%+48.06%+117.26% 4.54B
-3.67%-0.94%+293.81%+192.48% 3.4B
+0.43%+2.97%-24.27%-28.55% 2.58B
-0.45%+2.81%-22.96%-20.52% 2.02B
+1.22%-5.67%-49.32%-68.29% 1.99B
0.00%-1.52%-5.80%-25.71% 1.27B
-0.59%-2.31%+21.58%+36.29% 987M
0.00%-4.59%-11.72%-20.18% 936M
0.00%-0.93%+66.93%+42.28% 870M
Average -0.28%+0.34%+35.15%+25.01% 2.07B
Weighted average by Cap. -0.41%+1.45%+57.58%+51.46%

Financials

2026 *2027 *
Net sales 28.78B 4.39B 3.85B 3.57B 3.28B 6.19B 424B 6.28B 42.58B 16.66B 207B 16.49B 16.14B 717B 30.76B 4.7B 4.11B 3.82B 3.51B 6.61B 453B 6.71B 45.51B 17.81B 222B 17.63B 17.25B 766B
Net income 3.12B 476M 417M 387M 356M 670M 45.93B 680M 4.61B 1.81B 22.48B 1.79B 1.75B 77.64B 5.95B 909M 796M 739M 679M 1.28B 87.72B 1.3B 8.81B 3.45B 42.92B 3.41B 3.34B 148B
Net Debt 20.88B 3.19B 2.79B 2.59B 2.38B 4.49B 308B 4.56B 30.88B 12.09B 150B 11.96B 11.71B 520B 19.84B 3.03B 2.65B 2.46B 2.26B 4.27B 292B 4.33B 29.36B 11.49B 143B 11.37B 11.13B 494B
Logo Coloplast
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - ostomy care products (35.5%): bags and equipment used following intestinal operations; - hygiene products (32.2%): urine bags, plugs, urinary testing systems and sets, etc.; - wound care and skincare products (14.1%): wound dressings, bandages, creams and gels; - interventional urology products (10%); - voice and respiratory care products (8.2%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.5%), the United States (23.5%), the United Kingdom (14%), France (10.1%), Germany (9.7%) and other (41.2%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA